Filed: 5/14/2024ACC: 0001639101-24-000003
📋 What this filing means
BFAM PARTNERS (CAYMAN) LTD filed this quarterly 13F‑HR report disclosing 2 equity positions with a total reported market value of $3.94M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
2
Positions
$3.94M
Total AUM (reported)
4.55M
Total Shares
Allocation by class
NOTE 1.500% 9/0$3.92M99.3%
*W EXP 03/15/202$28.1K0.7%
Portfolio Concentration
Top 3$3.94M100.0%
Top 3 weight
100.0%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 4.55M
Sole
Full voting authority
4.55M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole2
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings2
Rows:
ZTO EXPRESS CAYMAN INC
SOLEShares4M
TypePRN
Market value$3.92M
99.29%
Sole
4M
Shared
0.00
None
0.00
YS BIOPHARMA CO LTD
SOLEShares550K
TypeSH
Market value$28.1K
0.71%
Sole
550K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ZTO EXPRESS CAYMAN INCSOLE | NOTE 1.500% 9/0 | 4M | PRN | $3.92M 99.29% | 4M | 0.00 | 0.00 |
YS BIOPHARMA CO LTDSOLE | *W EXP 03/15/202 | 550K | SH | $28.1K 0.71% | 550K | 0.00 | 0.00 |